Mit Schwarzkümmel gegen SARS-CoV-2

Zusammenfassung

Krebspatienten erkranken häufiger und schwerer an einer SARS-CoV-2-Infektion. Schwarzkümmel und seine Leitsubstanz Thymochinon wirken u.a. antiviral. Der Wirkungsmechanismus der antiviralen Wirkung gegen SARS-CoV-2 ist weitgehend aufgeklärt. Beide stimulieren und modulieren darüber hinaus auch die humorale und zelluläre Immunantwort. Die Signalwege der COVID-19-Komplikationen werden gehemmt und so wird einer pulmonalen Hypertonie und Lungenfibrose sowie einem Lungenödem und akutem Lungenversagen vorgebeugt.

Fünf explorative Studien weisen auf eine Wirksamkeit bei der COVID-19-Erkrankung hin. Die im Internet veröffentlichte Meta-Analyse mit 10 Studien ist von inakzeptabler Qualität und erlaubt keine Angabe zur Wirkgröße des Schwarzkümmels. Konfirmatorische Studien müssen die Ergebnisse zur Wirksamkeit überprüfen. Es wird vermutet, dass mit einer optimalen Kombination verschiedener Pflanzenwirkstoffe die effektivste Behandlungsstrategie gegen eine SARS-CoV-2-Infektion erzielt werden kann.

Eine Tagesdosis mit bis zu 50 mg Thymochinon kann ohne Sicherheitsbedenken oral eingenommen werden. Eigene Untersuchungen zeigen, dass kommerzielle Schwarzkümmelpräparate nur wenig Thymochinon enthalten. Ein wirkstoffkontrolliertes Präparat ist Voraussetzung für eine erfolgreiche Behandlung.

Cancer patients suffer more often and more severe from SARS-CoV-2 infections. Black seed and its co-acting leading compound thymoquinone act antiviral. The mechanism of action is broadly uncovered. Both also stimulate and modulate the humoral and cellular immune response. The signalling pathways of COVID-19 complications are inhibited and prevent pulmonary hypertension, lung fibrosis, lung edema and acute respiratory failure.

Five exploratory studies indicate effectiveness in COVID-19 infections. The meta-analysis published in the Web pooling 10 studies is of unacceptable quality and does not allow to define the effect size. Confirmatory studies are required to confirm the effectiveness of black seed. It may well be that an optimum combination of different plant-derived compounds provides the optimum treatment strategy against SARS-CoV-2 infections.

A daily dose of up to 50 mg thymoquinone can safely be orally consumed. Own investigations showed that commercial black seed preparations contain only low quantities of thymoquinone. Medications with a high content of thymoquinone are required for successful treatment.

Schlüsselwörter

Schwarzkümmel - Nigella sativa - Thymochinon - antiviral - antikanzerogen - Wirksamkeitsevidenz

Key Words

Black seed - Nigella sativa - thymoquinone - antiviral - anticancer effect - evidence of effectiveness

Publication History

Article published online:
07 June 2023

• Literatur

• 1 Adhikari B, Marasini BP, Rayamajhee B. et al. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID-19: A review. Phytother Res 2021; 35: 1298-1312
• 2 Afroz S, Fairuz S, Joty JA. et al. Virtual screening of functional foods and dissecting their roles in modulating gene functions to support post COVID-19 complications. J Food Biochem 2021; 45: e13961
• 3 Al-Haidari KA, Faiq TN, Ghareeb OA. Preventive value of black seed in people at risk of infection with COVID–19. PJMHS 2021; 15: 384-387. https://pjmhsonline.com/2021/jan/384.pdf
• 4 Al-Haidari KA, Faiq TN, Ghareeb OA. Clinical trial of black seeds against COVID – 19 in Kirkuk City/Iraq. Indian J Forensic Med Toxicol 2021; 15: 3393-3399 DOI: 10.37506/ijfmt.v15i3.15825.
• 5 Ashraf S, Ashraf S, Ashraf M. et al. for the COALITION COVID-19 Shaikh Zayed. Honey and Nigella sativa against COVID-19 in Pakistan (HNS-COVID-PK): A multi-center placebo-controlled randomized clinical trial. . https://www.medrxiv.org/content/10.1101/2020.10.30.20217364v4.full.pdf; version posted November 30, 2020
• 6 Bencheqroun H, Ahmed Y, Kocak M. et al. A randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and efficacy of ThymoQuinone Formula (TQF) for treating outpatient SARS-CoV-2. Pathogens 2022; 11: 551
• 7 Bin Abdulrahman KA, Bamosa AO, Bukhari AI. et al. The effect of short treatment with Nigella sativa on symptoms, the cluster of differentiation (CD) profile, and inflammatory markers in mild COVID-19 patients: A randomized, double-blind controlled trial. Int J Environ Res Public Health 2022; 19: 11798
• 8 ElGohary GM, Hashmi S, Styczynski J et al. The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 2022; 15(2): 45–53. DOI: 10.1016/j.hemonc.2020.07.005
• 9 Elgohary S, Elkhodiry AA, Amin NS. et al. Thymoquinone: A tie-breaker in SARS-CoV2-infected cancer patients?. Cells 2021; 10: 302
• 10 Goc A, Niedzwiecki A, Ivanov V. et al. Inhibitory effects of specific combination of natural compounds against SARS-CoV-2 and its Alpha, Beta, Gamma, Delta, Kappa, and Mu variants. Eur J Microbiol Immunol (Bp) 2022; 11: 87-94
• 11 Khaikin E, Chrubasik-Hausmann S, Kaya S, Zimmermann BF. Screening of thymoquinone content in Nigella sativa commercial products to identify a promising and safe study medication. Nutrients 2022; 14: 3501
• 12 Khan MT, Ali A, Wei X. et al. Inhibitory effect of thymoquinone from Nigella sativa against SARS-CoV-2 main protease. An in-silico study. Braz J Bio 2022; 84: e250667
• 13 Khazdair MR, Ghafari S, Sadeghi M. Possible therapeutic effects of Nigella sativa and its thymoquinone on COVID-19. Pharm Biol 2021; 59: 696-703
• 14 Koshak DAE, Koshak PEA. Nigella sativa L as a potential phytotherapy for coronavirus disease 2019: A mini review of in silico studies. Curr Ther Res Clin Exp 2020; 93: 100602
• 15 Koshak AE, Koshak EA, Mobeireek AF. et al. Nigella sativa for the treatment of COVID-19: An open-label randomized controlled clinical trial. Complement Ther Med 2021; 61: 102769
• 16 Malekmohammad K, Rafieian-Kopaei M. Mechanistic aspects of medicinal plants and secondary metabolites against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Curr Pharm Des 2021; 27: 3996-4007
• 17 NN. Nigella sativa for COVID-19: real-time analysis of all 20 studies. November 2022. Im Internet: https://c19early.org/ns
• 18 Ramalingam K, Kuttan R, Das Sivadasan S. et al. Safety assessment of a thymoquinone-rich black cumin oil (BlaQmax®): Acute and sub-chronic toxicity studies. J Nutr Food Sci 2021; 11: 1-8
• 19 Taysi S, Algburi FS, Mohammed Z. et al. Thymoquinone: a review of pharmacological importance, oxidative stress, COVID-19, and radiotherapy. Mini Rev Med Chem 2022; 22: 1847-1875
• 20 Zhao G, Kang J, Jiao K. et al. High expression of GRP78 promotes invasion and metastases in patients with esophageal squamous cell carcinoma. Dig Dis Sci 2015; 60: 2690-2699